Ben Shempseyan
Investor Relations
Replay available
Biofrontera Inc. (NASDAQ: BFRI) Q1 2026 earnings conference call, held 2026-05-14. Replay captured from the company's public earnings webcast.

Investor Relations
CEO, Chairman and Founder at Biofrontera
CCO
at ROTH Capital Partners
at Stonix
Good day, and welcome to Biofrontera Inc. First Quarter twenty twenty six Financial Results and Business Update Conference Call. All participant lines will be in a listen only mode. Please note this event is being recorded. I would like to turn the conference over to Ben Shempseyan, Investor Relations. Please go ahead. Good morning, and welcome to Biofrontera Inc. First Quarter twenty twenty six Financial Results and Business Update Conference Call. Please note that certain information discussed during today's call by management is covered under the Safe Harbor provisions of the Private Securities Litigation Reform Act. We caution listeners that Biofrontera's management will be making forward looking statements and that actual results may differ materially from those stated or implied by these forward looking statements due to risks and uncertainties associated with the company's business. All risks and uncertainties are detailed in and are qualified by the cautionary statements contained in Biofrontera's press releases and SEC filings, including the company's quarterly report on Form 10 Q for the quarter ended 03/31/2026, and the company's annual report on Form 10 ks for the year ended 12/31/2025. Also, this conference call contains time sensitive information that is accurate only as of the date of this live broadcast. Biofrontera undertakes no obligation to revise or update any forward looking statements to reflect events or circumstances after the date of this conference call, except as required by law. During today's call, there will be references to certain non GAAP financial measures. Biofrontera believes these measures provide useful information for investors, yet should not be considered as a substitute for GAAP nor should they be viewed as a substitute for o...